Qool Therapeutics, Inc. — Form D/A
Qool Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D amendment with the SEC on 2018-07-27. The offering totals $15.2M, of which $14.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-07-27
- Form: D/A
- Accession: 0001658096-18-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $15.2M
- Amount sold: $14.0M
- Remaining: $1.2M
- Investors: 76
- Date of first sale: 2017-11-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-281229
Issuer
- Name: Qool Therapeutics, Inc.
- CIK: 0001658096
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1455 ADAMS DRIVE, MENLO PARK, CA, 94025
- Phone: (650) 328-1426
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Amir Belson | Director | Fremont, CA |
| James Dennis | Director | Menlo Park, CA |
| Ron Dieck | Director | Menlo Park, CA |
| Beverly Huss | Director | Mountain View, CA |
| Fred Moll | Director | Westwood, MA |
| Amir Belson | Executive Officer | Fremont, CA |
| Beverly Huss | Executive Officer | Mountain View, CA |
| Todd Brinton | Director | Santa Clara, CA |
Other filings by this issuer (2)
More